Expression of schistosomal Cathepsin L1 in Escherichia coli and evaluation of its protective capacity in an animal challenge

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 15, Issue 2, 2009, Pages 289-304

  Miysato, P A ^a   Ramos, C R R ^a   Abreu, P A E ^a   Dias, W O ^a   Nascimento, C ^a   Ho, Paulo Lee ^a   Kawano, T ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Cathepsin L1; Cysteine proteinase; Immunogenicity; Schistosoma mansoni; Vaccine

Indexed keywords

ALUMINUM HYDROXIDE; CATHEPSIN L; CATHEPSIN L1; COMPLEMENTARY DNA; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; HETEROLOGOUS EXPRESSION; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PROVOCATION TEST; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINATION;

ANIMALIA; ESCHERICHIA COLI; MUS; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 67649598416     PISSN: 16789199     EISSN: 16789199     Source Type: Journal    
DOI: 10.1590/S1678-91992009000200011     Document Type: Article

References (31)

1. World Health Organization. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of the Joint WHO Expert Committees. WHO technical report series: 912. Geneva: World Health Organization. Available from: http://whqlibdoc.who.int/trs/WHO-TRS-912.pdf.
2. Bergquist, NR. Schistosomiasis vaccine development: progress and prospects. Mem Inst Oswaldo Cruz. 1998;93(Suppl I):95-101. (Pubitemid 128525402)
3. Chitsulo L, Engels D, Montresor A, Savioli L. The global status of schistosomiasis and its control. Acta Trop. 2000;77(1):41-51.
4. Al-Sherbiny M, Osman A, Barakat R, El Morshedy H, Bergquist NR, Olds R. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop. 2003;88(2):117-130
5. Engels D, Chitsulo L, Montresor A, Savioli L. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop. 2002;82(2):139-146 (Pubitemid 34518564)
6. Morgan JA, Dejong RJ, Snyder SD, Mkoji GM, Loker ES. Schistosoma mansoni and Biomphalaria: past history and future trends. Parasitology. 2001;123:S211-28.
7. McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev. 2008;21(1):225-242 (Pubitemid 351160017)
8. Bergquist NR, Al-Sherbiny M, Barakat R, Olds R. Blueprint for schistosomiasis vaccine development. Acta Trop. 2002;82(2):183-192 (Pubitemid 34520460)
9. Bergquist NR. Schistosomiasis vaccine development: approaches and prospects. Mem Inst Oswaldo Cruz. 1995;90(2):221-227
10. Dalton JP, Brindley PJ, Knox DP, Brady CP, Hotez PJ, Donnelly S, O'Neill SM, Mulcahy G, Loukas A. Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression. Int J Parasitol. 2003;33(5-6):621-640 (Pubitemid 36638541)
11. Tort J, Brindley PJ, Knox D, Wolfe KH, Dalton JP. Proteinases and associated genes of parasitic helminths. Adv Parasitol. 1999;43:161-266. (Pubitemid 29184935)
12. Halton DW. Nutritional adaptations to parasitism within the platyhelminthes. Int J Parasitol. 1997;27(6):693-704. (Pubitemid 27287946)
13. Smith AM, Dalton JP, Clough KA, Kilbane CL, Harrop SA, Hole N, Brindley PJ. Adult Schistosoma mansoni express cathepsin L proteinase activity. Mol Biochem Parasitol. 1994;67(1):11-19
14. Brady CP, Dowd AJ, Brindley PJ, Ryan T, Day SR, Dalton JP. Recombinant expression and localization of Schistosoma mansoni cathepsin L1 support its role in the degradation of host hemoglobin. Infect Immun. 1999;67(1):368-374
15. Bogitsh BJ, Dalton JP, Brady CP, Brindley PJ. Gut-associated immunolocalization of the Schistosoma mansoni cysteine proteases, SmCL1 and SmCL2. J Parasitol. 2001;87(2):237-241
16. Michel A, Ghoneim H, Resto M, Klinkert MG, Kunz W. Sequence, characterization and localization of a cysteine proteinase cathepsin L in Schistosoma mansoni. Mol Biochem Parasitol. 1995;73(1-2):7-18.
17. Dalton JP, Neill SO, Stack C, Collins P, Walshe A, Sekiya M et al. Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines. Int J Parasitol. 2003;33(11):1173-1181
18. Kesik M, Jedlina-Panasiuk L, Kozak-Cieszczyk M, Plucienniczak A, Wedrychowicz H. Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1). Vaccine. 2007;25(18):3619-3628
19. Bhandari P, Gowrishankar J. An Escherichia coli host strain useful for efficient overproduction of cloned gene products with NaCl as the inducer. J Bacteriol. 1997;179(13):4403-4406
20. Tendler M, Brito CA, Vilar MM, Serra-Freire N, Diogo CM, Almeida MS et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci USA. 1996;93(1):269-273
21. Ramos CRR, Abreu PAE, Nascimento ALTO, Ho PL. A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz J Med Biol Res. 2004;37(8):1103-1109
22. Sato Y, Cowell JL, Sato H, Burstyn DG, Manclarck CR. Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun. 1983;41(1):313-320
23. Verity CK, McManus DP, Brindley PJ. Vaccine efficacy of recombinant cathepsin D aspartic protease from Schistosoma japonicum. Parasite Immunol. 2001;23(3):153-162
24. Mulcahy G, O'Connor F, McGonigle S, Dowd A, Clery DG, Andrews SJ, Dalton JP. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine. 1998;16(9-10):932-939 (Pubitemid 28276004)
25. Chaves AC, Silveira E, Bezerra RP, Moreira KA, Lucena-Silva NLC, Abath FGC et al. Influence of partition parameters on a recombinant antigen of Schistosoma mansoni expressed on E. coli using poly(ethylene glycol)-hydroxypropyl starch aqueous two-phase system. World J Microbiol Biotechnol. 2002;18(7):645-648
26. Reszka N, Cornelissen JB, Harmsen MM, Biénkowska-Szewczyk K, de Bree J, Boersma WJ, Rijsewijk FA. Fasciola hepatica procathepsin L3 protein expressed by a baculovirus recombinant can partly protect rats against fasciolosis. Vaccine. 2005;23(23):2987-2993
27. Brindley PJ, Kalinna BH, Dalton JP, Day SR, Wong JY, Smythe ML, MacManus DP. Proteolytic degradation of host hemoglobin by schistosomes. Mol Biochem Parasitol.1997;89(1):1-9. (Pubitemid 27373663)
28. Dalton JP, Clough KA, Jones MK, Brindley PJ. Characterization of the cathepsin-like cysteine proteinases of Schistosoma mansoni. Infect Immun. 1996;64(4):1328-1334
29. Hu W, Brindley PJ, McManus DP, Feng Z, Han ZG. Schistosome transcriptomes: new insights into the parasite and schistosomiasis. Trends Mol Med. 2004;10(5):217-225 (Pubitemid 38581794)
30. Verjovski-Almeida S, De Marco R, Martins EA, Guimarães PE, Ojopi EP, Paquola, AC et al. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet. 2003;35(2):148-157
31. Piacenza L, Acosta D, Basmadjian I, Dalton JP, Carmona C. Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep. Infect Immun. 1999;67(4):1954-1961 (Pubitemid 29144421)